WeightWatchers’ stock has soared after the company said it is getting into the prescription drug weight loss business with the acquisition of Sequence. Sequence is a telehealth provider that offers users access to drugs used to treat diabetes and obesity under the brand names including Ozempic, Wegovy and Trulicity. The drugs all work by the […]

This post was originally published on Michael West.